Administration of cytostatic agents. How to prevent extravasation
Glaus, A.
Krankenpflege. Soins Infirmiers 87(6): 23-27
1994
ISSN/ISBN: 0253-0465 PMID: 8015261 Document Number: 436843
Document emailed within 1 workday
Related Documents
Rauh, J.; Pluntke, S.; Müller, C. 2004: Treatment of perivascular extravasation of cytostatic agents MMW Fortschritte der Medizin 146(31-32): 23-24; 26-27Fukuchi, S. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 119-123
Takemoto, T.; Yanai, H. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 133-139
Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Bonnetblanc, J.M.; Bordessoule, D.; Fayol, J.; Amici, J.M. 1996: Treatment of accidental extravasation of antitumor agents with dimethylsulfoxide and alpha-tocopherol Annales de Dermatologie et de Venereologie 123(10): 640-643
Schmidt, C.G. 1971: Alkylating cytostatic agents Der Internist 12(Suppl 1): 119-127
Brieghel, A.; Bille, I.; Sørensen, C. 1991: Cytostatic agents. Pharmacists on the ward Sygeplejersken 91(37): 18-19; 26
Halvorsen, S. 1971: Cytostatic agents in treatment of the nephrotic syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 737
Semb, K.A.; Jakobsen, E. 2003: Cardiovascular adverse effects of cytostatic agents Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 123(1): 44-45
Wisløff, F.; Brinch, L.; Bruserud, O.; Dahl, I.M.; Lamvik, J. 1994: Treatment with high-dose cytostatic agents Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(26): 3115-3116
Chlund, K. 1970: Treatment of ulcerative colitis with cytostatic agents Wiener Medizinische Wochenschrift 120(16): 274
Ignatova, M.S.; Korovina, N.A.; Levitskaia, S.V.; Fokeeva, V.V.; Lurbe, K.B. 1970: Experience with using certain cytostatic agents in glomerulonephritis in children Pediatriia 49(12): 40-47
Sauer, H. 1991: Cytostatic agents. 2: Cytostatically active antimetabolites Fortschritte der Medizin 109(27): 545-546
Steineck, G.; Wijkström, H.; Borghede, G. 1994: Treatment of bladder cancer with cytostatic agents Lakartidningen 91(5): 397-404
Karrer, K. 1970: Prevention of breast cancer recurrence--cytostatic agents Wiener Klinische Wochenschrift 82(25): 465-467
Wüst, G. 1972: Methods and results of neoplasm sensitivity tests using cytostatic agents Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 156-158
Terent'eva, T.G.; Bukhny, A.F.; Drunov, L.A.; Izrail'skaia, M.A. 1976: Role of the individual sensitivity to various cytostatic agents in children with neuroblastomas Antibiotiki 21(11): 1011-1015
Rübben, H.; Dahm, H.H.; Lutzeyer, W. 1982: Effect of intravesical instillation of cytostatic agents on the normal urothelium Der Urologe. Ausg. a 21(2): 116-117
Ochodnický, M. 1985: Calcium ions, calmodulin and acquired resistance to cytostatic agents Casopis Lekaru Ceskych 124(37): 1175-1176
Kodydková, K.; Krejsek, J. 2000: Resistance of cells in hematopoietic malignancies to cytostatic agents. Part 1 Casopis Lekaru Ceskych 139(18): 553-556